BC13

BC13: sourced facts only. name: "Among the newly synthesized compounds, BC13 exhibited potent inhibitory activity against CDK6 and BRD4." [PMID:39575863]; target: "Among the newly synthesized compounds, BC13 exhibited potent inhibitory activity against CDK6 and BRD4." [PMID:39575863]; target: "Among the newly synthesized compounds, BC13 exhibited potent inhibitory activity against CDK6 and BRD4." [PMID:39575863]; developer: "Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, People's Republic of China." [PMID:39575863]; stage: "In vivo experiments showed that BC13 has potent antitumor activity in the MDA-MB-231 xenograft mouse model, without observable side effects." [PMID:39575863]